[PDF] Top 20 Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment

... application of PVP-I seemed to have practically no influence on tumour recurrence, but in this group particular problems to distinguish between tumour and neighbouring inflammatory tissue were described by ... Voir le document complet

... Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Switzerland Received 8 June 2008; received in revised form 13 October 2008; accepted 12 November 2008; Available ... Voir le document complet

... multimodal treatment including surgery, combined with chemotherapy and/or radiotherapy ...unique treatment available for patients with advanced and unresectable disease, or who cannot sustain a heavy ... Voir le document complet

... Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited therapeutic options and treatment ef ...and mesothelioma development is very long, the local ... Voir le document complet

... number of patients, no external val- idation was ...number of patients, may help identifying the location of radio-resistant re- gions within the pre-treatment GTV to guide dose escal- ation ... Voir le document complet

... capacity of transfected cells on BioCoat Matrigel Invasion Chamber; representative image of YAP and TAZ extinction shown under the ...fication of colonies in soft agar after 21 ...capacity of ... Voir le document complet

... Isolation of human iPS cells using EOS lentiviral vectors to select for ...character of tumor growth. Neurobiology of Disease 29, 278– ... Voir le document complet

... nature of MM CSCs with respect to niche, interactions with the microenvironment, and most importantly the immune system and other proper- ties in vivo are as yet under ...the pleural or peritoneal cavities, ... Voir le document complet

... veloped larger tumors compared with CD105 high cells. CD105 is an ancillary-transforming growth factor b receptor, and it is not clear whether its differential expression in MPM cells is responsible for the ... Voir le document complet

... Pleural mesothelioma. Cytology and molecular diagnostics Abstract The definitive diagnosis of malignant mesothelioma (MM) in effusion cytology is often avoided or reluctantly made by cytolo- gy alone. The ... Voir le document complet

... Activation of Trk B receptors may be a key mechanism in tumor cell survival after detachment from extracellular matrix (a process called ‘anoikis’) ...levels of BDNF in malignant pleural fluid ... Voir le document complet

... Society of Thoracic Surgeons (ESTS) Biology Club aims at providing a comprehensive insight into the basic biology of the diseases we are ...experts of the field presented the current knowledge about ... Voir le document complet

... European Malignant Hyperthermia Group guideline for the investigation of malignant hyperthermia susceptibility Investigation of malignant hyperthermia (MH) ... Voir le document complet

... in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know ’ [Eur J Cardiothorac Surg ...in malignant pleural mesothelioma and lung cancer: what ... Voir le document complet

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignemen[r] ... Voir le document complet

... Staging and risk assessment . Staging includes imaging of the brain, ideally with MRI. If repeat imaging is deemed necessary to determine residual disease, it should be done within 24 – 48 h after surgery. Lumbar ... Voir le document complet

... present investigation, we showed that serum HA is elevated in patients with MPM but this marker had a moderate ability to discriminate between patients with MPM and those with other pleural ...lack ... Voir le document complet

... •To protect siRNA, to allow the diffusion into the cervical mucus and to cross the anionic cellular membrane, we use nanotherapy: siRNA is encapsulated in lipidic nanovectors to form LIPOPLEXES . In order to develop a ... Voir le document complet

... Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Received 25 August 2014; revised 15 January 2015 and 8 February 2015; accepted 12 February 2015 Malignant ... Voir le document complet

... population of cells in pleural effusions is tumorigenic The pleural effusion is a complex mixture of immune cells, mesothelial cells, fibroblasts, and cancer ...proportion of stromal ... Voir le document complet